The proapoptotic protein Bim is expressed de novo following withdrawal of serum survival factors. Here, we show that BimÀ/À fibroblasts and epithelial cells exhibit reduced cell death following serum withdrawal in comparison with their wild-type counterparts. 
Introduction
The pro-survival Bcl-2 proteins, such as Bcl-2 and Bclx L , typically contain four Bcl-2 homology (BH) domains, while the pro-death proteins include those with the BH1, 2 and 3 domains (Bax and Bak) and the 'BH3-only proteins' (BOPs), including Bim, Hrk/DP5, Bmf, Puma, Bid and Bad (Cory and Adams, 2002) . Bax and Bak proteins promote the release of apoptogenic factors from the mitochondria, but in viable cells are restrained by their binding to pro-survival Bcl-2 proteins. A variety of studies suggest that the BOPs bind to the prosurvival Bcl-2 proteins and neutralise them, thereby allowing Bax and/or Bak to initiate cell death (Puthalakath and Strasser, 2002) . Bim and Puma are the most effective BOPs for cell killing, probably because they can engage with all the pro-survival Bcl-2 proteins (Chen et al, 2005) . The different BOPs respond to different forms of cellular stress and are subject to regulation at both the transcriptional and posttranslational level (Puthalakath and Strasser, 2002) . For example, Puma is a transcriptional target of p53 (Nakano and Vousden, 2001 ), while Bad is phosphorylated and sequestered by 14-3-3 proteins so that it cannot bind to Bcl-2 proteins (Zha et al, 1996; Scheid et al, 1999; Datta et al, 2000) .
Bim is expressed de novo following withdrawal of survival factors (Dijkers et al, 2000; Whitfield et al, 2001; Reginato et al, 2003; Weston et al, 2003; Wang et al, 2004) . Bim mRNA increases due to inactivation of the protein kinase B (PKB) (Dijkers et al, 2000; Gilley et al, 2003) or ERK1/2 pathways , or due to activation of JNK (c-Jun N-terminal kinase) (Whitfield et al, 2001) . Alternative splicing of the Bim gene gives rise to multiple isoforms that differ in proapoptotic potency (O'Connor et al, 1998) due to differences in their post-translational regulation (Ley et al, 2005b) . Of the short, long and extra-long Bim proteins (Bim S , Bim L and Bim EL ), Bim S is the most effective killer and consists of the pro-death BH3 domain and a C-terminal membranetethering domain. Bim L and Bim EL contain a dynein light chain 1 (DLC1) interacting domain, allowing their sequestration at microtubules in viable cells (Puthalakath et al, 1999; Lei and Davis, 2003) . Bim EL , the least effective cell killer, contains a unique exon that encodes an ERK1/2 docking domain (Ley et al, 2005a) and ERK1/2 phosphorylation sites that control the proteasomal turnover of Bim EL Luciano et al, 2003; Ley et al, 2004; Marani et al, 2004; Ley et al, 2005a) .
Here, we define a new role for ERK1/2-dependent phosphorylation of Bim EL . We find that Bim is required for optimal cell death upon serum withdrawal and associates with Mcl-1 and Bcl-x L ; survival factors prevent this association by preventing Bim expression. However, we now show that survival factors can also promote the rapid dissociation of preformed Bim EL /Mcl-1 and Bim EL /Bcl-x L complexes by ERK1/2-dependent phosphorylation of Bim EL . Dissociation is not a consequence of Bim EL degradation, since proteasome inhibitors and mutations that prevent Bim EL ubiquitylation do not impair dissociation of Bim EL from pro-survival proteins; indeed, dissociation may contribute to Bim EL degradation. Our results provide new insights into the regulation of Bim EL and cell survival by the ERK1/2 pathway.
Results
Bim expression determines the rate and magnitude of cell death following serum withdrawal CCl39 fibroblasts die by apoptosis following withdrawal of serum survival factors Weston et al, 2003) . Bim has been implicated in cell death in neurons (Whitfield et al, 2001) , epithelial cells (Reginato et al, 2003; Wang et al, 2004) and haematopoietic cells deprived of trophic support (Bouillet et al, 1999) . Indeed, following serum starvation of CCl39 cells we observed a rapid increase in Bim EL , followed by a slower increase in expression of Bim L , whereas the expression of Bmf and Bax did not change ( Figure 1A ). Of the pro-survival proteins, Bcl-2 and Bcl-x L levels remained unchanged, but there was a gradual decrease in the expression of Mcl-1 ( Figure 1A ), although the kinetics and magnitude of this varied between experiments.
Death following withdrawal of cytokines is thought to proceed through the Bcl-2-inhibitable, cell intrinsic pathway. To test this, we transfected CCl39 cells with expression plasmids for Bcl-2 or Mcl-1 (or empty vector, pcD) together with a plasmid encoding EGFP-spectrin to identify transfected cells. Overexpression of Bcl-2 or Mcl-1, confirmed by Western blotting ( Figure 1B ), caused a reduction in cell death ( Figure 1C ). Thus, serum withdrawal-induced apoptosis in CCl39 cells proceeds through the cell intrinsic pathway since it is inhibited by Bcl-2 or Mcl-1. It was notable that expression of Bcl-2 or Mcl-1 did not block the increase in Bim expression under these conditions ( Figure 1B ). Increased Bim expression following serum withdrawal was highly reproducible and was also seen in Rat-1 cells, immortalised mouse embryo fibroblasts (iMEFs) and immortalised baby mouse kidney epithelial (iBMK) cells ( Figure 1D ), albeit with distinct kinetics in each cell line.
To address directly if Bim was involved in promoting cell death following serum withdrawal, we examined iMEFs derived from wild-type (WT) and BimÀ/À mice ( Figure 2A ). BimÀ/À iMEFs exhibited an approximate 90% reduction in peak caspase activation in comparison to their WT counterparts ( Figure 2B ). The BimÀ/À iMEFs also exhibited a delay and reduction in the accumulation of dead cells with sub-G 1 DNA ( Figure 2C ), but this was not persistent, and BimÀ/À iMEFs clearly started to die at later time points (72-96 h). Furthermore, there was no difference between WT and BimÀ/À iMEFs in long-term (7 day) clonogenic survival assays (K Ewings, K Balmanno and S Cook, unpublished observations). Similar results were obtained by comparing WT and BimÀ/À BMK cells ( Figure 2D) ; the BimÀ/À cells again exhibited a reduction, but not a complete inhibition, of cell death ( Figure 2E ). As a comparison, we confirmed that loss of Bim protected iBMK cells for up to 48 h of paclitaxel exposure (Supplementary Figure 1 ; Tan et al, 2005) . In contrast, loss of Bim provided some resistance to serum withdrawal at early time points, but by 48 h there was no difference in viability between WT and BimÀ/À BMK cells. These results, in two different cell systems, suggest that there is a major role for Bim in the initiation of caspase activation and cell death following serum withdrawal, but other redundant BOPs or alternative death pathways can substitute for Bim in promoting cell death at later time points.
Bim expressed following serum withdrawal associates with Bcl-x L and Mcl-1 but not Bax Bim promotes apoptosis by binding to pro-survival Bcl-2 proteins and neutralising their protective effect or, in the case of Bim S , perhaps by binding directly to Bax (Marani et al, 2002) . We examined which Bcl-2 proteins Bim interacted with by immunoprecipitation of Bcl-x L or Mcl-1 from CCl39 whole cell extracts (WCE) ( Figure 3A and B). Serum starvation increased Bim EL expression and the newly expressed Bim EL associated with Mcl-1 and Bcl-x L ( Figure 3A and B). While Bim also binds to Bcl-2 (O'Connor et al, 1998), we failed to identify an antibody that could immunoprecipitate Bcl-2 complexes from CCl39 cells.
During these studies we found that Bax associated with Bcl-x L and Mcl-1 in viable cells ( Figure 3A and B). Serum withdrawal (SF) caused a small decrease in the amount of Bax bound to Mcl-1 ( Figure 3A ), but a very pronounced dissociation of Bax from Bcl-x L complexes, commensurate with the binding of Bim EL ( Figure 3B ). To investigate this further, we immunoprecipitated Bax using the N-20 N-terminal antibody. The N-20 epitope is exposed by a conformational change in response to apoptotic insults, but the presence of Triton X-100 in the lysis buffer ensured that all the Bax had undergone this conformational change (Marani et al, 2002) . Bax immunoprecipitates (IPs) from viable cells contained Bcl-2, Bcl-x L and Mcl-1 but no Bim EL ( Figure 3C ). Upon serum starvation, a treatment that results in Bim binding to pro-survival proteins ( Figure 3A and B), the amount of Bcl-2, Bcl-x L and Mcl-1 bound to Bax decreased ( Figure 3C ). In addition, while serum starvation increased Bim expression, we failed to detect Bim L or Bim EL in Bax IPs ( Figure 3C) Figure 4A ). When added to cells at the time of serum withdrawal, thrombin inhibited Bim expression ( Figure 4B , input WCE) and so prevented its recruitment into Mcl-1 complexes ( Figure 4B , IP Mcl-1); addition of fresh FBS was equally effective. Quantification of these blots ( Figure 4C ) confirmed that thrombin blocked Bim expression and so prevented its binding to Mcl-1. In the course of these studies, we noted that addition of thrombin to cells that had been serum starved for 6 h was still able to protect cells from cell death ( Figure 4D ). Since assembly of Bim EL /Mcl-1 complexes was already apparent after 6 h of serum withdrawal ( Figure 4B and E), we examined the effect of acute thrombin stimulation on the preassembled Bim EL /Mcl-1 complex. CCl39 cells were serum starved for 6 h to induce the assembly of a preformed Bim EL /Mcl-1 complex. Stimulation with thrombin for 15 min had no impact on the turnover of Bim EL or the total amount of Bim EL in whole-cell extracts ( Figure 4E , input WCE, quantified in Figure 4F ), but pro- Figure 2A) . Furthermore, dissociation of Bim EL from Bcl-x L complexes was also seen in starved WT iMEFs re-stimulated with FBS, confirming that this was not unique to CCl39 cells (Supplementary Figure 2B) .
Activation of ERK1/2 is necessary and sufficient to promote the dissociation of Bim EL from Mcl-1 and Bcl-x L
The ERK1/2 and PKB pathways promote cell survival and regulate Bim (Dijkers et al, 2000; Gilley et al, 2003; Weston et al, 2003) , so we used selective inhibitors to determine which pathway was responsible for the dissociation of Bim EL from Mcl-1. Stimulation of serum-starved CCl39 cells with thrombin caused dissociation of Bim EL from Mcl-1 ( Figure 5A , IP Mcl-1) and U0126, an inhibitor of MEK1/2, blocked ERK1/2 phosphorylation and Bim EL phosphorylation ( Figure 5A , input WCE) and prevented the thrombinstimulated dissociation of Bim EL from Mcl-1 ( Figure 5A , IP Mcl-1). In contrast, LY294002, a PI3 0 -kinase inhibitor, prevented PKB phosphorylation, but did not prevent Bim EL dissociation from Mcl-1 ( Figure 5A ).
To determine if the ERK1/2 pathway was sufficient to dissociate Bim EL , we used CR1-11 cells , a clone of CCl39 cells expressing the conditional protein kinase DRaf-1:ER*, which selectively activates ERK1/2 in response to treatment with 4-hydroxytamoxifen (4-HT). A 1 h stimulation with 4-HT promoted ERK1/2, phosphorylation of Bim EL ( Figure 5B , input WCE) and resulted in dissociation of Bim EL from preformed Bim EL /Mcl-1 complexes ( Figure 5B , IP Mcl-1), although the total amount of Bim in whole-cell extracts was not affected ( Figure 5B , input WCE). All these effects were reversed by treatment with U0126. DRaf-1:ER* also promoted the ERK1/2-dependent dissociation of preformed Bim EL /Bcl-x L complexes (Supplementary Figure 2C ). Thus, activation of the ERK1/2 pathway is necessary and sufficient to promote dissociation of endogenous Bim EL from endogenous Mcl-1 or Bcl-x L , two major pro-survival proteins.
ERK1/2-dependent dissociation of Bim EL /Mcl-1 complexes is not a consequence of Bim EL degradation
Phosphorylation of Bim EL by ERK1/2 promotes its proteasome-dependent destruction , so it was important to establish the relationship between dissociation and destruction. Dissociation of Bim EL from Mcl-1 was readily apparent within 15 min of FBS stimulation (Supplementary Figure 2A ), whereas emetine chase experiments revealed that significant turnover of endogenous Bim EL only occurred between 20 min and 1 h (Supplementary Figure 3A and B). However, to be sure, we devised a series of experiments to determine whether the dissociation of Bim EL from Mcl-1 was simply a consequence of ERK1/2-dependent Bim EL destruction. First, CR1-11 cells were serum starved for 6 h to assemble the Bim EL /Mcl-1 complex and then re-stimulated with 4-HT in the presence of the proteasome inhibitor MG132. Following activation of DRaf-1:ER*, phosphorylated forms of Bim EL accumulated due to the presence of MG132, and were detected in the whole-cell extracts ( Figure 6A , input WCE). This phosphorylation of Bim EL caused a 60-70% reduction in the amount of Bim EL associated with Mcl-1 ( Figure 6A and B), similar to that observed in response to thrombin ( Figure 4F) ; dissociation of Bim EL was apparent within 30 min, maximal by 1 h and persisted for as long as DRaf-1:ER* remained active. These results, using a pharmacological inhibitor of the proteasome, show that dissociation of Bim EL takes place even when total Bim EL levels are constant and so is not a consequence of it being degraded by the proteasome. In addition, we observed that a mutant Figure 6C ). Since this mutant cannot be ubiquitylated (Akiyama et al, 2003) , this provides further molecular genetic evidence that ERK1/2-dependent dissociation of Bim EL was not a consequence of its ubiquitylation or proteasomal degradation. Finally, growth factor-dependent dissociation of Bim EL from Mcl-1 proceeded in the presence of cycloheximide and MG132, indicating that ERK1/2 was promoting Bim EL dissociation from pre-existing complexes rather than reducing the stability of newly expressed Bim EL before it has a chance to bind (Supplementary Figure 3C) . Together, these results indicate that dissociation of Bim EL from pro-survival proteins does not result from its destruction. We also performed the reciprocal experiment by examining the kinetics of Bim EL /Mcl-1 association following inhibition of the ERK1/2 pathway. CCl39 cells growing in complete medium (10% FBS) were serum starved in the presence of the ERK1/2 pathway-selective inhibitor PD184352 for between 20 and 120 min. This treatment led to the immediate inactivation of ERK1/2, dephosphorylation of Bim EL and an increase in the amount of Bim EL bound to Mcl-1 ( Figure 6D ). Significantly, while serum withdrawal (with or without ERK1/2 inhibition) can increase Bim EL expression, this is not apparent until approximately 2 h Weston et al, 2003) , whereas the increase in association of Bim EL with Mcl-1 was apparent within 20 min, a time point at which total Bim EL and Mcl-1 levels were unchanged ( Figure 6D ). These results indicate that inhibition of ERK1/2 causes the rapid dephosphorylation of Bim EL and its association with its prosurvival target proteins.
Bim EL dissociation is reversible upon inhibition of the ERK1/2 pathway When degradation of Bim EL was blocked, we found that the dissociation of Bim EL from Mcl-1 was readily reversible. For example, when serum-starved CR1-11 cells were stimulated with 4-HT for 2 or 4 h in the presence of MG132 to prevent Bim EL degradation, we observed a 70% reduction in the amount of Bim EL bound to Mcl-1, even though total Bim EL levels did not change (Supplementary Figure 4A and B) . In contrast, if cells were treated with 4-HT for 2 h to phosphorylate and dissociate Bim EL and then treated with U0126 for a further 2 h to inhibit ERK1/2, Bim EL was dephosphorylated and a significant proportion was found reassociated with Mcl-1 (Supplementary Figure 4A and B) . A potential explanation for this came when we subjected these cell extracts to a crude subcellular fractionation. Regardless of its phosphorylation status, Bim EL remained in the same COX-IV containing heavy membrane fraction as Mcl-1 rather than being released into the cytosol (Supplementary Figure 4C) . These results suggest that when the proteasome is inhibited, both Bim EL and Mcl-1 are retained on the mitochondria following their dissociation and so can readily reassociate when Bim EL is dephosphorylated following ERK1/2 inhibition. This may explain why we have been unable to visualise the dissociation of Bim EL from Mcl-1 using immunofluorescence microscopy. It also demonstrates the dynamic and reversible nature of ERK1/2-dependent Bim EL dissociation. Figure 7A ), one of which (Ser 65 , p2) is an in vitro and in vivo ERK1/2 phosphorylation site (Luciano et al, 2003; Ley et al, 2004; Marani et al, 2004) . To determine the role of proline-directed phosphorylation of Bim EL , we analysed a mutant (HA-Bim EL 6Ala) in which all six Ser-Pro or Thr-Pro motifs had been mutated to non-phosphorylatable residues. As a control, we observed that Bim EL with three mutations in the BH3 domain (HA-Bim EL DBH3) exhibited greatly reduced binding to Mcl-1 in HR1 cells, despite expressing at the highest level of all three constructs ( Figure 7C ). HA-Bim EL 6Ala expressed at much higher levels than HA-Bim EL ( Figure 7C , input WCE), but was not phosphorylated and did not dissociate in response to ERK1/2 activation, whereas HA-Bim EL did ( Figure 7C , Mcl-1 IP), demonstrating that phosphorylation of proline-directed sites on Bim EL is required for its ERK1/2-dependent dissociation from Mcl-1.
Since phosphorylation-dependent dissociation from Mcl-1 was only observed for Bim EL , we focused on the three sites ) sites had a partial effect on the ERK1/2-dependent phosphorylation and dissociation of Bim EL . In contrast, mutation of the p2 site (Ser 65 ) strongly inhibited phosphorylation of Bim EL and completely prevented its ERK1/2-dependent dissociation from Mcl-1. Mutation of the proline-directed sites (p4-p6) had no effect on the dissociation of Bim EL from Mcl-1 (K Ewings and S Cook, unpublished observations), consistent with the fact that Bim L did not dissociate upon ERK1/2 activation ( Figure 7B ). These results demonstrate that phosphorylation of Bim EL at Ser 65 is absolutely required for ERK1/ 2-dependent dissociation of Bim EL from Mcl-1.
A logical prediction of these experiments is that phosphomimetic forms of Bim EL , in which the p2 or p1-p3 sites are mutated to acidic residues (Asp or Glu), should bind poorly to Mcl-1. However, we found that the binding of such mutant forms of Bim EL to Mcl-1 was highly variable so that it was not possible to draw any reliable conclusions. It would appear that acidic substitutions at Ser 65 , either alone or in combination with mutation of Ser 55 and Ser
73
, cannot faithfully mimic the phosphorylation events in vivo. As an alternative, we examined the distribution of Bim EL phosphorylated at Ser 65 using a phospho-Ser 65 -specific antibody. HR1 cells were transfected with HA-Bim EL and then serum starved before stimulating with 4-HT in the presence or absence of U0126. Extracts were divided and either Mcl-1 or HA-Bim EL was immunoprecipitated. Both the HA-Bim EL and the endogenous Bim EL underwent an ERK1/2-dependent phosphorylation ( Figure 8B , input WCE) and dissociated from Mcl-1 ( Figure 8B , Mcl-1 IP). We were unable to detect phosphoSer 65 Bim EL in whole-cell extracts, but the antibody worked well when we immunoprecipitated HA-Bim EL from these cell extracts; this allowed us to demonstrate 4-HT-dependent increases in phospho-Ser 65 Bim EL , which were inhibited by U0126 treatment, confirming that Ser 65 is a target for ERK1/2 in vivo ( Figure 8B, HA IP) Bim EL mutants that fail to bind to pro-survival proteins exhibit accelerated turnover Finally, we investigated whether the dissociation of Bim EL was linked to its proteasomal degradation. For example, although phosphorylation might be the direct signal for degradation of Bim EL , an alternative possibility was that Bim EL that was not bound to a pro-survival Bcl-2 protein was the primary target for degradation, with phosphorylation simply serving to 'liberate' Bim EL from Mcl-1 or Bcl-x L . This possibility was further supported by our observation that phosphorylation of Ser 65 , a site required for ERK1/2-dependent degradation of Bim EL (Ley et al, 2004; Luciano et al, 2003) , was also required for its dissociation from Mcl-1 (Figure 8) . A logical prediction from this model is that a Bim EL mutant defective for binding to pro-survival Bcl-2 proteins should exhibit a shorter half-life than the WT protein, so we compared the half-life of WT HA-Bim EL with that of the HA-Bim EL DBH3 mutant, which exhibits greatly reduced binding to pro-survival Bcl-2 proteins including Mcl-1 ( Figure 7C ). These constructs were expressed in HEK293 cells, which were then serum starved and subjected to an emetine chase protocol to examine their turnover. Immunoblotting for total ERK1/2, a relatively stable protein under these conditions, confirmed equal loading. Under serum-free conditions, HA-Bim EL was stable in the presence of emetine for up to 12 h, whereas the HA-Bim EL DBH3 mutant clearly turned over in the presence of emetine (Figure 9) . A trivial explanation for the enhanced turnover of the HABim EL DBH3 protein was that mutations in the BH3 domain of Bim EL compromised protein folding, so that the mutant protein did not express well. However, we reproducibly observed that HA-Bim EL DBH3 actually expressed at considerably higher levels than the WT HA-Bim EL (Figures 7C and 9) . Furthermore, HA-Bim EL DBH3 was still able to undergo ERK1/ 2-dependent phosphorylation ( Figure 7C ), suggesting that the mutant protein was folding normally. These results indicate that dissociation of Bim EL from pro-survival proteins is sufficient to promote its degradation.
Discussion
Bim is involved in promoting cell death following serum withdrawal The initiation of CCl39 cell death following serum withdrawal is a caspase-dependent process that requires new gene expression Weston et al, 2003) and proceeds through the mitochondrial death pathway ( Figure 1 ). The increase in expression of Bim in CCl39 cells, Rat-1 cells, iMEFs and iBMKs following serum withdrawal implied a potential role for Bim in promoting cell death. By comparing WT and BimÀ/À iMEFs and iBMK epithelial cells we have now demonstrated that Bim expression is ratedetermining for cell death following serum withdrawal; indeed, Bim appears to play a major role in initiating caspase activation in iMEFs following serum withdrawal. Taken together with other recent studies, it appears that the de novo expression of Bim is involved in initiating apoptosis following withdrawal of trophic support in a variety of cell types (Bouillet et al, 1999; Dijkers et al, 2000; Whitfield et al, 2001; Reginato et al, 2003; Wang et al, 2004) . However, in iMEFs and especially iBMKs, the protection afforded by loss of Bim was transient; this is consistent with the role of Bim in promoting apoptosis being dependent on the death stimulus, tissue type and the presence of other redundant BOPs.
A likely alternative to Bim in these studies is Bad, which is normally negatively regulated by RSK-and PKB-dependent phosphorylation (Datta et al, 1997 (Datta et al, , 2000 Bonni et al, 1999; Lizcano et al, 2000) . While BadÀ/À MEFs are not protected against serum withdrawal-induced death (Ranger et al, 2003) , presumably reflecting the prominent role for Bim in MEFs (Figure 2 ), BadÀ/À mammary epithelial cells are protected against withdrawal of EGF (Ranger et al, 2003) . Similarly, loss of Bim only affords partial protection against NGF withdrawal in neurons (Whitfield et al, 2001 ) and this may reflect a role for Hrk/DP5 (Harris and Johnson, 2001) . Alternatively, while Bim may regulate a classical caspase-dependent apoptosis at early times following serum withdrawal, other caspase-independent pathways (Chipuk and Green, 2005) may ensure cell death in the long term.
Newly expressed Bim associates with pro-survival proteins following serum withdrawal
In viable CCl39 cells maintained in complete medium, Bax associated with Bcl-2, Bcl-x L and Mcl-1. Following serum withdrawal, newly expressed Bim EL associated with Bcl-x L and Mcl-1, and this was accompanied by the dissociation of Bax from the pro-survival proteins, especially Bcl-x L . These results fit well with the features of the 'displacement' model , since we failed to observe an association between Bax and Bim EL (or Bim L ). However, it is important to point out that only Bim S has been proposed to bind directly to Bax (Marani et al, 2002) , and we struggled to detect the very low levels of Bim S in CCl39 cells. Furthermore, we cannot rule out the possibility that the Bax N-20 antibody disrupts interactions with Bim EL , although this seems unlikely since Bax binding to Bcl-x L or Mcl-1 was readily detectable in N-20 immune complexes. Exposure of an occluded N-terminal region in Bax, including the N-20 epitope, occurs in response to stress but may not be sufficient for commitment to cell death (Makin et al, 2001) . Subsequent changes towards the C-terminus occur commensurate with dissociation of Bax from pro-survival Bcl-2 proteins and may be more relevant to the initiation of cell death. A similar multistep process seems to operate for Bak activation . We previously showed that serum withdrawal caused the initial N-terminal change in Bax . Since this change is reversible (Makin et al, 2001 ), we studied changes in the repertoire of Bax complexes associated with the later conformational change(s) by Figure 6A and B) and a Bim EL mutant that could not be ubiquitylated (Akiyama et al, 2003) underwent ERK1/2-dependent dissociation normally ( Figure 6C) ; thus, dissociation of Bim EL is not a consequence of its proteasome-dependent degradation. We also observed that inhibition of ERK1/2 for as little as 20 min was sufficient to promote the binding of Bim EL to Mcl-1 without changing total Bim EL or Mcl-1 expression ( Figure 6D ). Since Bim must interact with pro-survival proteins to promote cell death (O'Connor et al, 1998; Willis et al, 2007) , these results describe a completely novel mechanism by which ERK1/2 can prevent Bim EL -dependent cell death; namely, by reducing the binding of Bim EL to its target pro-survival proteins. While it has previously been shown that preassembled Bad/Bcl-x L complexes can be dissociated by phosphorylation of Bad (Scheid et al, 1999) , this is the first such demonstration for Bim, or other BOPs, and may explain reports that ERK1/2 can inhibit the activity of Bim EL , without apparent changes in its abundance (Wang et al, 2004; Reginato et al, 2005) . ERK1/2-dependent dissociation was unique to Bim EL , consistent with exon 3 (unique to Bim EL ) harbouring the ERK1/2 docking domain and phosphorylation sites (Ley et al, 2005b) . Furthermore, two lines of evidence strongly suggest that Ser In summary, we have shown that expression of Bim contributes to fibroblast and epithelial cell death following withdrawal of serum survival factors. Furthermore, by demonstrating that ERK1/2-dependent phosphorylation of Bim EL causes the rapid dissociation of Bim EL /Mcl-1 and Bim EL / Bcl-x L complexes, we have defined a completely new mechanism by which survival factors can antagonise Bim EL function, providing a further explanation for the reduced efficacy of Bim EL relative to Bim S and Bim L (O'Connor et al, 1998) . Mutation of Ser 65 Ala has been shown to enhance the toxicity of Bim EL and it was assumed that this was due to stabilisation of the protein (Luciano et al, 2003; Ley et al, 2004) . While this may well be the case, our results suggest that an additional effect of this mutation is to prevent growth factor-dependent dissociation of Bim EL from its target pro-survival proteins. This may prove important in a variety of physiological and pathophysiological settings in which survival signals are limiting, including the developing CNS, immune system and in tumour cells. 
Materials and methods

Antibodies
Cells and cell culture
Culture of CCl39 and CR1-11 , HEK293 , HR1 (Boughan et al, 2006) and WT and BimÀ/À E1A-immortalised iBMK cells (Tan et al, 2005) have been described previously. WT and BimÀ/À iMEFs were provided by David Huang, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia. MEFs were generated from E13-14.5 embryos and immortalised (at passages 2-4) with SV40 large T antigen. The mice used had been backcrossed (410 generations) to the C57BL/6 genetic background and their genotype determined as described previously (Bouillet et al, 1999) .
Assay of cell death
Assay of caspase activity by DEVDase assay and cell death by propidium iodide staining were described previously Austin and Cook, 2005) .
Cell extracts and immunoprecipitation
Following stimulation, cells were lysed in TG lysis buffer, as described previously . TG lysates were used for immunoprecipitations with the following antibodies: Bax N-20, Santa Cruz (sc-493) with protein G sepharose beads; Bcl-x L , Cell Signalling Technology (2762) and Mcl-1, Santa Cruz (sc-819) with protein A sepharose beads.
Supplementary data
Supplementary data are available at The EMBO Journal Online (http://www.embojournal.org).
